Impacting News from Novavax, CymaBay Therapeutics and Sanofi SA
The Grant That Rallied the Stock
Novavax (NVAX) stock jumped sky-high following the announcement that the firm has been granted up to $384 million by the coalition for Epidemic Preparedness innovation. The grant is to help the advancement in the clinical development of the firm’s SARS-CoV-2 (COVID-19) vaccine and of scaling-up manufacturing.
The stock is currently trading at $38.09 UP $13.59.